Melanoma-associated retinopathy.
Elsheikh S, Gurney SP, Burdon MA.
Clin Exp Dermatol. 2020 Mar;45(2):147-152. doi: 10.1111/ced.14095. Epub 2019 Nov 19.
Melanoma-associated retinopathy.
Singh AD, Milam AH, Shields CL, De Potter P, Shields JA.
Am J Ophthalmol. 1995 Mar;119(3):369-70. doi: 10.1016/s0002-9394(14)71185-7.
Unilateral Melanoma-Associated Retinopathy Case Report.
Peeters R, Peeters F, Jacob J, Draganova D, Casteels I, Poesen K, Balikova I.
Case Rep Ophthalmol. 2023 Oct 6;14(1):498-506. doi: 10.1159/000533769. eCollection 2023 Jan-Dec.
Melanoma-associated retinopathy after starting immunotherapy for metastatic cutaneous melanoma.
Ferrara M, Adams W, Kotagiri A.
Eye (Lond). 2022 Dec;36(12):2361-2362. doi: 10.1038/s41433-022-02057-8. Epub 2022 Apr 15.
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review.
Heng JS, Kim JM, Jones DK, Stoessel KM, Weiss SA, Sznol M, Kluger HM, Walter SD, Silverstein NA, Pointdujour-Lim R.
BMJ Open Ophthalmol. 2022 Jan 3;7(1):e000889. doi: 10.1136/bmjophth-2021-000889. eCollection 2022.
Cancer-Associated Retinopathy.
Singh D, Tripathy K.
2024 Feb 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Melanoma-associated retinopathy: does autoimmunity prolong survival?
Chan C, O'Day J.
Clin Exp Ophthalmol. 2001 Aug;29(4):235-8. doi: 10.1046/j.1442-9071.2001.00425.x.
Melanoma-associated retinopathy with presentation of transient multiple hyper-autofluorescent dots.
Lin CY, Shao YC, Chen WL, Chen SN.
Kaohsiung J Med Sci. 2024 Feb;40(2):198-200. doi: 10.1002/kjm2.12792. Epub 2023 Dec 7.
Cutaneous melanoma-associated retinopathy.
Kim RY, Retsas S, Fitzke FW, Arden GB, Bird AC.
Ophthalmology. 1994 Nov;101(11):1837-43. doi: 10.1016/s0161-6420(94)31092-x.
Metastatic Cutaneous Melanoma Presenting With Melanoma-Associated Retinopathy.
Heberton M, Azher T, Council ML, Khanna S.
Dermatol Surg. 2019 Apr;45(4):606-607. doi: 10.1097/DSS.0000000000001599.
